News

The incidence of invasive meningococcal disease fell from 67% in the first quarter of the study period to 4% during the last quarter at a hospital in Spain.

The findings echo the guidelines published by IDSA/SHEA in 2018.

Concerns of at-risk patients forgoing condoms may be driving the reluctance of some clinicians to prescribe the preventive regimen.

A study reports that a respiratory virus infection diagnosis was not linked with a decrease in antibiotic exposure and use of respiratory viral panels did not affect clinical outcomes.

A new study finds that regular use of tenofovir gel helped reduce the risk of genital herpes acquisition in women in sub-Saharan Africa.

Following implementation of stewardship program-guided blood culture communication process, the time to optimal therapy was 9.2 hours shorter for patients at Saint Luke’s Hospital.

Ibuprofen succeeded in fighting S aureus in a laboratory setting, although it’s not clear whether the same effect would hold true in patients with systemic infections.

Rats and other pests pose significant problems for urban areas in the US.

As outpatient medical care becomes more common, are we forgetting the role of infection control?

Hospital-onset sepsis is twice as deadly as community-onset sepsis and increases the risk of death 3-fold, according to the results of a cohort study comprising 2.3 million adult patients.

The FDA has accepted New Drug Applications for oral and IV formulations of Nabriva Therapeutics’ lefamulin for the treatment of community-acquired bacterial pneumonia.

The FDA has approved room temperature stable, premixed vancomycin injections, which will be available in ready-to-use bags.

Although IV antibiotics have been the standard of care for bone and joint infections, a new study finds that oral antibiotics were non-inferior.

A new study reports that many health care workers had the ability to neutralize the Ebola virus, despite never exhibiting symptoms of infection.

A computer simulation model developed by NYU investigators uses math to forecast influenza activity.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Hospital-acquired conditions fell 13% between 2014 and 2017, according to a new report from the Agency for Healthcare Research and Quality.

The FDA has finalized its guidance on how to synchronize development of antimicrobials and antimicrobial susceptibility test devices.

ART is associated with increased waist size in some people with HIV, and a new study aims to shed light on the factors involved.

As several Zika virus vaccine candidates undergo clinical trials, a group of investigators is taking an alternate approach to quell transmission by genetically engineering mosquitoes to be resistant to the virus.

As flu activity remains elevated in all regions of the United States for the fifth week in a row, a new study quantifies the impact of flu vaccination last season.

The FDA has granted issued a Complete Response Letter to Motif Bio regarding the New Drug Approval for iclaprim.

The FDA has approved triclabendazole (Egaten) for the treatment of fascioliasis, a neglected tropical disease in patients 6 years of age and older

As political and economic turmoil envelop the nation, crumbling health care infrastructure has reintroduced vaccine-preventable diseases and providers have limited resources to treat the infections.

The FDA has authorized a phase 2 study of PUR1900, an inhaled formulation of itraconazole, for the treatment of allergic bronchopulmonary aspergillosis.

The bold promise in last week’s State of the Union address is achievable, but may mean keeping the Affordable Care Act.

The NIH has announced that a trial evaluating the safety of and adherence to a vaginal ring containing dapivirine and oral tablets for PrEP is now underway in southern Africa.